Michael C. Gruber, Managing Partner at Salveo Capital, invests primarily in early-stage (seed and startup) ancillary. See sector focus and contact routes.
Michael C. Gruber, Managing Partner at Salveo Capital, invests primarily in early-stage (seed and startup) ancillary technology and service companies within the legalized cannabis ecosystem, including sectors like ag-tech, financial services, software, and bio-pharma [1][2][6]. His distinctive thesis targets businesses that enable industry operators to function more efficiently while avoiding highly regulated "plant-touching" entities, though he makes select investments in cultivation and dispensaries [2][3]. Notable portfolio companies include Würk (regulatory tech), Treez (retail software), PathogenDX (testing), Ascend Wellness (multistate operator), and Harborside (retailer) [4][5]. Gruber leverages 30 years of experience in IT, agriculture, and energy to support cannabis firms, aiming for 4X–10X returns with IRRs exceeding 35% [1][4].
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Chicago.
Investors like Michael C. Gruber · Full investor directory · Investor access · Company funding database